(Q79243467)

English

Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis

scientific article published on 01 September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

drotrecogin alfa

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Marya Hill-Popper

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

John Stasinos

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Constantia Petrou

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Robert A. Fowler

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595571

27 March 2024

Gillian D. Sanders

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595571

27 March 2024

Alan M. Garber

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595571

27 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14595571

27 March 2024

publication date

1 September 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

full work available at URL

https://api.elsevier.com/content/article/PII:S0883944103000819?httpAccept=text/xml

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

https://api.elsevier.com/content/article/PII:S0883944103000819?httpAccept=text/plain

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Journal of Critical Care

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

181-91; discussion 191-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Efficacy and safety of recombinant human activated protein C for severe sepsis

1

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Treating patients with severe sepsis

2

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

6

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

7

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Efficacy and safety of recombinant human activated protein C for severe sepsis

10

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

14

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research

15

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

16

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Clinical scoring systems for determining the prognosis of gastrointestinal bleeding

18

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Measurement of health state utilities for economic appraisal

20

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Methodology for measuring health-state preferences--II: Scaling methods

21

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

One thousand health-related quality-of-life estimates

22

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

23

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.

27

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties

28

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Cost-effectiveness of automated external defibrillators on airlines.

29

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Intensive care unit patient follow-up. Mortality, functional status, and return to work at six months

32

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Mortality and quality of life after intensive care for critical illness

35

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit.

36

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

A quantitative method for cost reimbursement and length of stay quality assurance in multiple trauma patients

37

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Stroke treatment economic model (STEM): predicting long-term costs from functional status.

38

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction

39

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients

40

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

An economic evaluation of activated protein C treatment for severe sepsis

42

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Gains in life expectancy from medical interventions--standardizing data on outcomes

44

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Early goal-directed therapy in the treatment of severe sepsis and septic shock

45

1 reference

10.1016/J.JCRC.2003.08.009

https://api.crossref.org/works/10.1016/J.JCRC.2003.08.009

27 March 2024

Identifiers

10.1016/J.JCRC.2003.08.009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14595571%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79243467&oldid=2112722089"